CardiaTec Bio

CardiaTec Biosciences is a TechBio startup founded in 2021 in the United Kingdom. The company's slogan "Decoding the biology behind cardiovascular disease" accurately reflects its focus on employing computational methods to decode the biology behind cardiovascular disease. CardiaTec leverages large and high-dimensional human omics data to better navigate complex disease biology to discover novel and differentiated therapeutics. The company recently secured a notable £1.40M Pre Seed Round investment on 06 July 2022, with prominent investors including Crista Galli Ventures, Apex Ventures, Laidlaw Scholars Ventures, o2h Ventures, and University of Cambridge Enterprise. As a biotechnology company dedicated to unravelling the mysteries of cardiovascular disease, CardiaTec Biosciences holds significant promise in advancing the development of innovative therapeutics for this critical health issue.